Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy.

We demonstrated that in subcohorts of patients treated with ICI alone or in combination with chemotherapy, MR was a significant or nearly significant, respectively, predictor of rwOS (Fig. 4 , Suppementary Materials Fig.

also in 3,287 other papers